Skip to main content
Clinical Trials/CTRI/2024/06/068585
CTRI/2024/06/068585
Recruiting
Phase 1

A Randomized, Controlled, Double Blind clinical study to evaluate use of Hydron Alkaline Ionized Water (HAIW) in healthy participants - NI

Hydron Alkaline Aqua Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Hydron Alkaline Aqua Pvt. Ltd.
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Hydron Alkaline Aqua Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • 1\.Healthy Male and Female participants in the age group of 21\-40 Years
  • 2\.Subjects of female gender or non\-pregnant, non\-lactating females. A urine pregnancy test is required for all female subjects of childbearing potential unless female subject has had a hysterectomy, tubal ligation, or is greater than 2 years postmenopausal.
  • 3\.Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

Exclusion Criteria

  • 1\.Known cases of any Severe and Chronic disease.
  • 2\.Known subject of any active malignancy.
  • 3\.Subjects giving history of significant cardiovascular event less than 12 weeks prior to randomization.
  • 4\.Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  • 5\.Known subjects of having active metabolic or gastrointestinal diseases that may interfere with nutrient absorption, metabolism, or excretion, excluding diabetes.
  • 6\.Subjects with Diabetes and Hypertension
  • 7\.Subjects using any other investigational drug within 1 month prior to recruitment.
  • 8\.Known hypersensitivity to alkaline water
  • 9\.Pregnant and Lactating females.
  • 10\.Subjects currently participating in any other Clinical study.

Outcomes

Primary Outcomes

Not specified

Similar Trials